Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases. Kawano Y, Wang X, Patel NJ, Qian G, et al. J Rheumatol 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742.

Read + Share

Amedeo Smart

Independent Medical Education

Kawano Y, Wang X, Patel NJ, Qian G, et al. Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases. J Rheumatol 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742.
PMID: 37839812